Showing results (771-780 of 911) with videos related to
Sort By:
Pageof 92
The Lancet. Psychiatry|March 11, 2022
Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trialChristian Schmidt-Kraepelin, Sandra Feyerabend, Christina Engelke, et al.The Lancet. Psychiatry|March 16, 2022
Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in female outpatients with anorexia nervosa (ANTOP study): 5-year follow-up of a randomised controlled trial in GermanyWolfgang Herzog, Beate Wild, Katrin E Giel, et al.The Lancet. Psychiatry|July 9, 2017
Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of SwedenClarissa Bauer-Staeb, Lena Jörgensen, Glyn Lewis, et al.The Lancet. Psychiatry|August 18, 2018
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching studyRené S Kahn, Inge Winter van Rossum, Stefan Leucht, et al.The Lancet. Psychiatry|November 19, 2016
Violence against women and mental healthSian Oram, Hind Khalifeh, Louise M HowardThe Lancet. Psychiatry|March 14, 2016
Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental HealthAllison C Nugent, Nicolas D Iadarola, Frank G Miller, et al.The Lancet. Psychiatry|September 12, 2015
Heterogeneity of postpartum depression: a latent class analysisThe Lancet. Psychiatry|September 12, 2015
The brain disease model of addiction: is it supported by the evidence and has it delivered on its promises?Wayne Hall, Adrian Carter, Cynthia ForliniThe Lancet. Psychiatry|September 12, 2015
Rehabilitative therapies for chronic fatigue syndrome: a secondary mediation analysis of the PACE trialTrudie Chalder, Kimberley A Goldsmith, Peter D White, et al.The Lancet. Psychiatry|September 12, 2015
An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trialAnja Fischer, Johanna Schröder, Eik Vettorazzi, et al.Pageof 92